Pathway launches SensiTrop HIV tropism assay in US
This article was originally published in Clinica
Executive Summary
SensiTrop, a new molecular heteroduplex tracking assay (HTA) designed to determine the co-receptor tropism status of HIV infected patients, has been launched in the US by Pathway Diagnostics.